TEVA &lt;TEVIY> SELLS PROMEDICO SUBSIDIARY
  Teva Pharmaceutical Industries Ltd,
  based in Israel, said it sold its wholly owned Promedico
  subsidiary, to foreign investors for four mln dlrs.
      It said the book value of the unit is about 2.2 mln dlrs.
      Teva said it will continue to market Promedico's products
  through its wholly owned subsidiary, Salomon, Levin and Elstein
  Ltd.
  

